ESR1 and neoplasm: Future analyses of VTE rates in patients with CIA following RBC transfusion and ESA administration may consider Khorana score, chemotherapy regimen and schedule, INR, tumor estrogen‐receptor positivity, and stage of malignancy at the time of VTE.